Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04753190 · ClinicalTrials.gov registry record · NA

Light Timing Study

A NA study of Sleep and Circadian Rhythm, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
113
Enrollment target
1
Study location

NCT04753190 is a NA study of Sleep and Circadian Rhythm that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 113 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04753190, a NA study of Sleep and Circadian Rhythm, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
113 participants
Enrollment target
1
Study location

Study Summary

Chronic circadian misalignment and sleep restriction peak during late adolescence, and are associated with morning daytime sleepiness, poor academic performance, conduct problems, depressed mood, suicidal ideation, substance use, insulin resistance, and obesity. Bright light exposure from light boxes can shift rhythms earlier (phase advance) to facilitate earlier sleep onset and reduce morning circadian misalignment and the associated risks. To phase advance circadian rhythms, the investigators' PRCs showed that the ideal time to begin light exposure was slightly before wake-up time and light should be avoided around bedtime because this is when light produces maximum phase delay shifts. An unexpected finding from these results, however, was a second advancing region in the afternoon (\~6 to 9 h after habitual wake-up time) suggesting that afternoon light may have more circadian phase advancing ability than traditionally thought. The overall goal of this mechanistic study is to follow-up on the unexpected PRC findings and test whether individually-timed afternoon light alone and in combination with morning bright light can shift circadian rhythms earlier in older adolescents. Four groups will be compared in a randomized parallel group design: afternoon bright light, morning bright light, morning + afternoon bright light, and a dim room light control. Adolescents will complete a 2-week protocol. After a baseline week with a stable sleep schedule, adolescents will live in the laboratory for 7 days. Sleep/dark and the time of bright light exposure will gradually shift earlier. Bright light (\~5000 lux) will be timed individually based on his/her stable baseline sleep schedule. The first 3-h morning bright light exposure will begin 1 h before wake on the first morning. The first 3-h afternoon bright light exposure will begin 5 h after wake. The morning + afternoon exposures will begin at the same times, but each exposure will be 1.5 h so that a total of 3 h of bright li

Interventions

  • BEHAVIORAL Baseline Sleep Satiation and Phase Stabilization
  • BEHAVIORAL Gradually Shifted Sleep

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2022-08-22
Est. Completion 2026-06-30
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT04753190

The ClinicalTrials.gov registry entry for NCT04753190 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Baseline Sleep Satiation and Phase Stabilization is the first listed.

NCT04753190 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04753190 about?

NCT04753190 is a clinical study titled "Light Timing Study". Chronic circadian misalignment and sleep restriction peak during late adolescence, and are associated with morning daytime sleepiness, poor academic performance, conduct problems, depressed mood, suicidal ideation, substance use, insulin resistance, and obesity. Bright light exposure from light boxe...

What is the current status of trial NCT04753190?

This trial is currently recruiting. It is a NA study. The enrollment target is 113 participants. The study started on 2022-08-22. Estimated completion is 2026-06-30.

What conditions does trial NCT04753190 study?

This clinical trial studies the following conditions: Sleep, Circadian Rhythm, Adolescence, Light, Chronobiology.

What interventions are being tested in trial NCT04753190?

The interventions under investigation include: Baseline Sleep Satiation and Phase Stabilization (BEHAVIORAL), Gradually Shifted Sleep (BEHAVIORAL).

Who is sponsoring clinical trial NCT04753190?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04753190 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.